Literature DB >> 8618872

Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated.

R J Diebold1, M J Eis, M Yin, I Ormsby, G P Boivin, B J Darrow, J E Saffitz, T Doetschman.   

Abstract

Transforming growth factor beta 1 (TGF beta 1)-null mice die fro complications due to an early-onset multifocal inflammatory disorder. We show here that cardiac cells are hyperproliferative and that intercellular adhesion molecule 1 (ICAM-1) is elevated. To determine which phenotypes are primarily caused by a deficiency in TGF beta 1 from those that are secondary to inflammation, we applied immunosuppressive therapy and genetic combination with the severe combined immunodeficiency (SCID) mutation to inhibit the inflammatory response. Treatment with antibodies to the leukocyte function-associated antigen 1 doubled longevity, reduced inflammation, and delayed heart cell proliferation. TGF beta 1-null SCID mice displayed no inflammation or cardiac cell proliferation, survived to adulthood, and exhibited normal major histocompatibility complex II (MHC II) and ICAM-1 levels. TGF beta 1-null pups born to a TGF beta 1-null SCID mother presented no gross congenital heart defects, indicating that TGF beta 1 alone does not play an essential role in heart development. These results indicate that lymphocytes are essential for the inflammatory response, cardiac cell proliferation, and elevated MHC II and ICAM-1 expression, revealing a vital role for TGF beta 1 in regulating lymphocyte proliferation and activation, which contribute to the maintenance of self tolerance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8618872      PMCID: PMC40327          DOI: 10.1073/pnas.92.26.12215

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

Review 1.  The transforming growth factor-beta family.

Authors:  J Massagué
Journal:  Annu Rev Cell Biol       Date:  1990

2.  A severe combined immunodeficiency mutation in the mouse.

Authors:  G C Bosma; R P Custer; M J Bosma
Journal:  Nature       Date:  1983-02-10       Impact factor: 49.962

3.  Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype.

Authors:  A G Geiser; J J Letterio; A B Kulkarni; S Karlsson; A B Roberts; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

4.  Temporal differentiation and migration of substance P, serotonin, and secretin immunoreactive enteroendocrine cells in the mouse proximal small intestine.

Authors:  K D Aiken; K A Roth
Journal:  Dev Dyn       Date:  1992-08       Impact factor: 3.780

5.  Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells.

Authors:  C W Czarniecki; H H Chiu; G H Wong; S M McCabe; M A Palladino
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

6.  Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1.

Authors:  M Isobe; H Yagita; K Okumura; A Ihara
Journal:  Science       Date:  1992-02-28       Impact factor: 47.728

7.  Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.

Authors:  M M Shull; I Ormsby; A B Kier; S Pawlowski; R J Diebold; M Yin; R Allen; C Sidman; G Proetzel; D Calvin
Journal:  Nature       Date:  1992-10-22       Impact factor: 49.962

8.  Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.

Authors:  A B Kulkarni; C G Huh; D Becker; A Geiser; M Lyght; K C Flanders; A B Roberts; M B Sporn; J M Ward; S Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

9.  Transforming growth factor beta 1 systemically modulates granuloid, erythroid, lymphoid, and thrombocytic cells in mice.

Authors:  J A Carlino; H R Higley; J R Creson; P D Avis; Y Ogawa; L R Ellingsworth
Journal:  Exp Hematol       Date:  1992-09       Impact factor: 3.084

10.  Transforming growth factor-beta 1 in heart development.

Authors:  G L Engelmann; K D Boehm; M C Birchenall-Roberts; F W Ruscetti
Journal:  Mech Dev       Date:  1992-08       Impact factor: 1.882

View more
  67 in total

1.  Latency-associated peptide of transforming growth factor beta enhances mycobacteriocidal immunity in the lung during Mycobacterium bovis BCG infection in C57BL/6 mice.

Authors:  K A Wilkinson; T D Martin; S M Reba; H Aung; R W Redline; W H Boom; Z Toossi; S A Fulton
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

2.  Serial killer: angiotensin drives cardiac hypertrophy via TGF-beta1.

Authors:  Michael D Schneider
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

Review 3.  TGF-beta, T-cell tolerance and anti-CD3 therapy.

Authors:  Ramireddy Bommireddy; Thomas Doetschman
Journal:  Trends Mol Med       Date:  2004-01       Impact factor: 11.951

Review 4.  TGFβ biology in cancer progression and immunotherapy.

Authors:  Rik Derynck; Shannon J Turley; Rosemary J Akhurst
Journal:  Nat Rev Clin Oncol       Date:  2020-07-24       Impact factor: 66.675

5.  TGF-β signaling plays an essential role in the growth and maintenance of intervertebral disc tissue.

Authors:  Hongting Jin; Jie Shen; Baoli Wang; Meina Wang; Bing Shu; Di Chen
Journal:  FEBS Lett       Date:  2011-03-21       Impact factor: 4.124

6.  Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo.

Authors:  R Agah; P A Frenkel; B A French; L H Michael; P A Overbeek; M D Schneider
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

Review 7.  Regulatory T cells and immune tolerance in the intestine.

Authors:  Oliver J Harrison; Fiona M Powrie
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-07-01       Impact factor: 10.005

8.  TGF beta 1 inhibits Ca2+-calcineurin-mediated activation in thymocytes.

Authors:  Ramireddy Bommireddy; Ilona Ormsby; Moying Yin; Gregory P Boivin; George F Babcock; Thomas Doetschman
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

Review 9.  Murine models of colorectal cancer.

Authors:  Joshua M Uronis; David W Threadgill
Journal:  Mamm Genome       Date:  2009-05-15       Impact factor: 2.957

10.  Epistatic interactions between Tgfb1 and genetic loci, Tgfbm2 and Tgfbm3, determine susceptibility to an asthmatic stimulus.

Authors:  Julia Freimuth; Frederic F Clermont; Xiaozhu Huang; Angela DeSapio; Taku A Tokuyasu; Dean Sheppard; Rosemary J Akhurst
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.